CECyd K. Eaton

Cyd K. Eaton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cyd K. Eaton has a total of 159 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adherence, self-management, and beyond in the artificial intelligence era: a commentary on what pediatric psychologists need

    by Cyd K Eaton, Adrian Ortega, Gabriella Bobadilla, Polina Poliakova, Sara E Wetter-Wren, Shayna Skelley Coburn, Daniela Ghio, Jaya L Mallela, Hannah Manis, Katie A McIntyre, et al.

  • Collaborative decision-making among pediatric nephrology providers: a qualitative study

    by Cyd K. Eaton, Cozumel S. Pruette, Hyeyoung Ryu, Chelsea Ng, Zixuan Xu, Qiulin Qu, Jaime Snyder, Wanda Pratt, Aaron Wightman, Ari H. Pollack

  • Open Access

    User Engagement Strategies for Digital Medication Adherence Interventions: A Systematic Review and Meta-Analysis

    by Serena Thaw-Poon, Isabella Diaz, Candice Acevedo, Tanisa Goyal, Dayanara Salinas, Jannine Balakid, Cyd Eaton

    Background: Medication adherence is critical for chronic disease management, yet poor adherence remains an unsolved challenge. Digital health interventions are promising to support medication adherence but are limited by poor user engagement with the tools. Understanding which strategies effectively support user engagement could improve the efficacy and sustainability of these interventions.Purpose: This systematic review and meta-analysis characterized strategies used to support user engagement in digital adherence interventions with the well-established Behavior Change Technique Taxonomy and evaluated whether these strategies were associated with medication adherence and user engagement outcomes. Methods: Electronic databases (Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase via Ovid, MEDLINE, PsycInfo, and Web of Science Core Collection) were searched (4/18/2025) to identify randomized controlled trials of app-based digital adherence interventions for people with chronic medical conditions taking oral medications, published in English between 2020 and 2025. User engagement strategies were characterized with the Behavior Change Technique Taxonomy. Meta-regression models evaluated associations between specific techniques and study outcomes. Risk of bias was characterized with the Risk of Bias-1 measure. Results: The 60 studies included for review predominantly included adults with cardiovascular disease, hypertension, and type 2 diabetes (median N=117, IQR=72.0-204.5). All but one included at least one user engagement strategy appropriate to characterize with the Behavior Change Technique Taxonomy. The most common techniques were Prompts/cues (90%), Instruction on how to perform the behavior (70%), Adding objects to the environment (35%), Feedback on behavior (28%), Self-monitoring of behavior (25%), Credible source (22%), Goal setting (behavior) (20%), and Self-monitoring outcome(s) of behavior (20%). Prompts/cues were frequently paired with another behavior change technique (54%). User engagement was rarely measured as an outcome, and thus, it was not possible to evaluate this outcome in the meta-analysis. In the 44 studies included in the meta-analysis of medication adherence outcomes, there were no statistically significant associations with user engagement techniques. Conclusions: Digital adherence interventions commonly include strategies to support user engagement, particularly prompts/cues, but it remains unknown whether these strategies translate to actual user engagement. No user engagement strategy was associated with medication adherence outcomes. This may reflect variability across study samples and medication adherence measurement approaches, threats to internal validity, or reliance on ineffective strategies. Further research should continue to evaluate which engagement strategies support sustained digital adherence tool use and improved adherence outcomes.

  • Local environment, socioeconomic status, and health literacy: key modifiers of adherence in pediatric nephrology

    by Cyd K. Eaton, Cozumel S. Pruette

    Pediatric nephrology patients have high rates of treatment nonadherence, thus increasing their risk for poor health outcomes. Key modifiers of adherence among pediatric nephrology patients include local environment (place of residence, school setting, clinic setting), socioeconomic status, and health literacy. Where patients live affects access to health care, community, and school resources that support adherence and disease management. Socioeconomic challenges, such as lower income, food insecurity, and housing instability, may lead patients and families to prioritize immediate survival needs over adherence. Lower health literacy is common among pediatric nephrology patients and their caregivers and may contribute to difficulties communicating with care teams, understanding health information, and implementing medical recommendations. This educational review aims to (1) conceptualize local environment, socioeconomic status, and health literacy, as well as their interconnections, within an established socio-ecological framework of the individual, family, community, and health care system factors impacting pediatric adherence, (2) synthesize recent literature on the influence of these domains on adherence in pediatric nephrology, and (3) highlight strategies to mitigate barriers within each domain and promote adherence among pediatric nephrology patients and their families. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information

  • Adding Perspective to Employee Mental Wellness: A Population Health and Psychoeducational Approach to Screening and Care Connection

    by Matthew E. Peters, Harriet Martyn, Susan M. Carr, Yunzhi Wang, Cyd K. Eaton, Allison M. Bailey, Paul M. Kim

    Purpose: Describe the Perspectives of Psychiatry approach and how it was integrated into an employer-based mental health engagement program. Design: Retrospective cohort study. Setting: Workplace-based. Sample: 913 employees. Intervention: The Johns Hopkins Balance program is a novel, employer-initiated mental health engagement program. The Balance program integrates the Perspectives of Psychiatry (Perspectives) ideology for mental health care and takes a population health and psychoeducational approach to screening and care connection. Measures: Utilization and engagement rates, algorithm-based mental health symptom risk, Perspectives -based risk. Analysis: Chi squared tests for risk categorization associations, odds ratio high risk categorization, frequency and percentage of referral types. Results: 94% (860/913) of participants who registered completed the Balance assessment and 14% (130/913) completed a care concierge visit. Referrals were placed for 69% (90/130) of employees who completed a care concierge visit. A person identified as high risk by the standardized assessments had 6.74 (4.38, 10.71) times the odds of endorsing a concern on at least one of the Perspectives . An additional 28 participants were identified as high risk based on their own concern after scoring low risk on the standardized assessment. Of the 117 referrals placed, 96.6% (113/117) were in individuals scoring high risk on the assessment. Conclusion: A population health and psychoeducational approach to employer-based mental health engagement can successfully identify risk and connect employees to care.


  • Open Access

    Tacrolimus IPV Group Membership Does Not Consistently Track With Electronically Monitored or Self-reported Adherence in Adolescent and Young Adult Kidney Transplant Recipients

    by Cyd K. Eaton, Cozumel S. Md Pruette, Kristin A. Riekert, Nazanin Yousefzadeh, Ahna L. Pai, Sandra Md Amaral, Vikas R. Dharnidharka, Bärbel Knäuper, Jodi M. Smith, Susan L. Furth, et al.

    Background.: High intrapatient variability (IPV) of tacrolimus trough concentrations (SD ≥ 2, coefficient of variation (CV%) ≥ 30) is associated with rejection and graft loss and may indicate nonadherence. However, the association between tacrolimus IPV and electronically monitored or self-reported adherence is unknown. Methods.: This secondary analysis of the TAKE-IT (Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial) compared electronically monitored and self-reported adherence between participants with high and low tacrolimus IPV among 103 adolescent and young adult kidney transplant recipients (mean age = 15.18 y, 59% male, 60% White, 65% >1-y posttransplant). Results.: Electronically monitored daily taking and timing adherence were not significantly associated with tacrolimus IPV group in binomial generalized linear mixed effects models: Participants with tacrolimus SD ≥ 2 or CV% ≥ 30 were no less likely to take each daily dose than those below these cutoffs (SD < versus ≥ 2: odds ratio [OR]; 0.84, 95% confidence interval [CI], 0.48-1.47; P = 0.54 and CV% < versus ≥ 30: OR, 0.72; 95% CI, 0.43-1.21; P = 0.22). Participants with tacrolimus SD ≥ 2 or CV% ≥ 30 were no less likely to take each daily dose on time than those below these cutoffs (SD < versus ≥ 2: OR, 0.70; 95% CI, 0.40-1.23; P = 0.21 and CV% < versus ≥ 30: OR, 0.68; 95% CI, 0.40-1.16; P = 0.15). Electronically monitored averages of doses taken, doses taken early/late, and differences from expected dose time were associated with tacrolimus IPV (P < 0.05) but were poor classifiers of IPV group membership (area under the curve < 0.70). Self-reported adherence was not associated with tacrolimus IPV. Conclusions.: Tacrolimus IPV group membership does not consistently track with behavioral adherence measures. Relying on tacrolimus IPV group membership may misidentify nonadherence in adolescent and young adult kidney transplant recipients.


  • Open Access

    Patient-reported assessment of bulbar function in spinal muscular atrophy (SMA): Validation of a self-report scale

    by Maureen A Lefton-Greif, Lisa Belter, Jill Jarecki, Mary Schroth, Yong Zeng, Thomas O Crawford, Cyd Eaton

    Background: Bulbar dysfunction is a well-recognized burden experienced by individuals with spinal muscular atrophy (SMA). Metrics that capture the impact of these problems are lacking. Objectives: To develop and validate an SMA-Bulbar Scale that captures and quantifies patient-reported experiences with bulbar dysfunction. Methods: Cure SMA database members were invited to complete online surveys and a 31-item Bulbar Scale developed by the authors with reference to both bulbar dysfunction in the literature and consultations with SMA-dedicated health care providers, pharmaceutical companies, and persons affected by SMA. Results: 166 adults with SMA reported a range of bulbar dysfunctions. The most common problems, occurring more than 80% of the time, were prolonged meal times, difficulty with mouth opening, and swallowing pills. In addition, 10% of the respondents reported a worsening feeding function over the course of their lives. Across the diverse array of bulbar functions, exploratory and confirmatory factor analyses of responses identified three coherent dimensions of bulbar dysfunction: Swallowing; Mealtimes and Communication; and Breath Sounds, Speech, Voice, and Secretion Management. Higher scores of overall bulbar dysfunction, (p < .001) and each factor (p < .001), were reported by respondents with any degree of feeding restrictions. Sex, age, or use of SMA disease-modifying treatment did not correlate with bulbar scores. Conclusions: This patient-reported scale of bulbar function in adults with a wide range of SMA severity captures and quantifies the variable manifestations of experienced bulbar impairment. With preliminary evidence of validity, the scale supports efforts to standardize accurate identification of bulbar dysfunction, incorporate the perspectives of people with SMA on key areas of their daily functioning, provide metrics essential for meaningful endpoints in clinical trials, inform practice guidelines, and promote advancement of the regulatory science needed for the evaluation and development of therapeutic interventions. Identification of three coherent dimensions of bulbar dysfunction may improve further investigations.


  • Top Cited Papers
    Open Access

    User Engagement With mHealth Interventions to Promote Treatment Adherence and Self-Management in People With Chronic Health Conditions: Systematic Review

    by Cyd Eaton, Natalie Vallejo, Xiomara McDonald, Jasmine Wu, Rosa Rodríguez, Nishanth Muthusamy, Nestoras Mathioudakis, Kristin A Riekert

    Background: There are numerous mobile health (mHealth) interventions for treatment adherence and self-management; yet, little is known about user engagement or interaction with these technologies. Objective: This systematic review aimed to answer the following questions: (1) How is user engagement defined and measured in studies of mHealth interventions to promote adherence to prescribed medical or health regimens or self-management among people living with a health condition? (2) To what degree are patients engaging with these mHealth interventions? (3) What is the association between user engagement with mHealth interventions and adherence or self-management outcomes? (4) How often is user engagement a research end point? Methods: Scientific database (Ovid MEDLINE, Embase, Web of Science, PsycINFO, and CINAHL) search results (2016-2021) were screened for inclusion and exclusion criteria. Data were extracted in a standardized electronic form. No risk-of-bias assessment was conducted because this review aimed to characterize user engagement measurement rather than certainty in primary study results. The results were synthesized descriptively and thematically. Results: A total of 292 studies were included for data extraction. The median number of participants per study was 77 (IQR 34-164). Most of the mHealth interventions were evaluated in nonrandomized studies (157/292, 53.8%), involved people with diabetes (51/292, 17.5%), targeted medication adherence (98/292, 33.6%), and comprised apps (220/292, 75.3%). The principal findings were as follows: (1) >60 unique terms were used to define user engagement; “use” (102/292, 34.9%) and “engagement” (94/292, 32.2%) were the most common; (2) a total of 11 distinct user engagement measurement approaches were identified; the use of objective user log-in data from an app or web portal (160/292, 54.8%) was the most common; (3) although engagement was inconsistently evaluated, most of the studies (99/195, 50.8%) reported >1 level of engagement due to the use of multiple measurement methods or analyses, decreased engagement across time (76/99, 77%), and results and conclusions suggesting that higher engagement was associated with positive adherence or self-management (60/103, 58.3%); and (4) user engagement was a research end point in only 19.2% (56/292) of the studies. Conclusions: The results revealed major limitations in the literature reviewed, including significant variability in how user engagement is defined, a tendency to rely on user log-in data over other measurements, and critical gaps in how user engagement is evaluated (infrequently evaluated over time or in relation to adherence or self-management outcomes and rarely considered a research end point). Recommendations are outlined in response to our findings with the goal of improving research rigor in this area. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42022289693; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022289693


  • Antidepressant nonadherence and sexual dysfunction among young adult males: the cross-sectional YAMAN study

    by Matthew J. Rabinowitz, Oscar Li, Ellen H. Pil, Cyd K. Eaton, Taylor P. Kohn, Nora M. Haney, Amin S. Herati

    Purpose Selective serotonin reuptake inhibitors are associated with high rates of nonadherence and sexual dysfunction, yet the correlation between these findings in young adult men is poorly characterized. We aimed to evaluate if young adult men are less willing to adhere to antidepressant treatment due to intolerable side effects, such as sexual dysfunction. Methods Deidentified, compensated survey that assessed baseline demographics, PHQ-8 and GAD-7 scores, attitudes towards antidepressant medication side effects, and perceptions of antidepressant medications including selective serotonin reuptake inhibitors, bupropion, and mirtazapine. Results From 665 delivered surveys, 505 respondents completed their survey (response rate: 76%), of which 486 were included for final analysis. After seeing common side effect profiles, our sample’s willingness to take sexual function-sparing agents, such as bupropion or mirtazapine, was significantly greater than selective serotonin reuptake inhibitors (p < 0.001), with no significant difference between bupropion and mirtazapine (p = 0.263). The negative influence of erectile dysfunction and anorgasmia scored significantly higher than other common antidepressant side effects like weight gain, nausea, and dry mouth (range: p < 0.001, p = 0.043). With the exception of insomnia, participants indicated that experiencing sexual dysfunction while taking an antidepressant medication would lead to nonadherence at a significantly higher frequency than any other side effect assessed (range: p < 0.001, p = 0.005). Conclusion The risk of experiencing sexual side effects when taking antidepressants could lead young adult men to become nonadherent to these medications. Strategies to augment the effectiveness of antidepressants, such as shared decision-making and the use of sexual function-sparing agents, are critical.


  • Open Access

    Cross-Cutting mHealth Behavior Change Techniques to Support Treatment Adherence and Self-Management of Complex Medical Conditions: Systematic Review

    by Cyd K Eaton, Emma McWilliams, Dana Yablon, Irem Kesim, Renee Ge, Karissa Mirus, Takeera Sconiers, Alfred Donkoh, Melanie Lawrence, Cynthia George, et al.

    Background: Mobile health (mHealth) interventions have immense potential to support disease self-management for people with complex medical conditions following treatment regimens that involve taking medicine and other self-management activities. However, there is no consensus on what discrete behavior change techniques (BCTs) should be used in an effective adherence and self-management–promoting mHealth solution for any chronic illness. Reviewing the extant literature to identify effective, cross-cutting BCTs in mHealth interventions for adherence and self-management promotion could help accelerate the development, evaluation, and dissemination of behavior change interventions with potential generalizability across complex medical conditions. Objective: This study aimed to identify cross-cutting, mHealth-based BCTs to incorporate into effective mHealth adherence and self-management interventions for people with complex medical conditions, by systematically reviewing the literature across chronic medical conditions with similar adherence and self-management demands. Methods: A registered systematic review was conducted to identify published evaluations of mHealth adherence and self-management interventions for chronic medical conditions with complex adherence and self-management demands. The methodological characteristics and BCTs in each study were extracted using a standard data collection form. Results: A total of 122 studies were reviewed; the majority involved people with type 2 diabetes (28/122, 23%), asthma (27/122, 22%), and type 1 diabetes (19/122, 16%). mHealth interventions rated as having a positive outcome on adherence and self-management used more BCTs (mean 4.95, SD 2.56) than interventions with no impact on outcomes (mean 3.57, SD 1.95) or those that used >1 outcome measure or analytic approach (mean 3.90, SD 1.93; P=.02). The following BCTs were associated with positive outcomes: self-monitoring outcomes of behavior (39/59, 66%), feedback on outcomes of behavior (34/59, 58%), self-monitoring of behavior (34/59, 58%), feedback on behavior (29/59, 49%), credible source (24/59, 41%), and goal setting (behavior; 14/59, 24%). In adult-only samples, prompts and cues were associated with positive outcomes (34/45, 76%). In adolescent and young adult samples, information about health consequences (1/4, 25%), problem-solving (1/4, 25%), and material reward (behavior; 2/4, 50%) were associated with positive outcomes. In interventions explicitly targeting medicine taking, prompts and cues (25/33, 76%) and credible source (13/33, 39%) were associated with positive outcomes. In interventions focused on self-management and other adherence targets, instruction on how to perform the behavior (8/26, 31%), goal setting (behavior; 8/26, 31%), and action planning (5/26, 19%) were associated with positive outcomes. Conclusions: To support adherence and self-management in people with complex medical conditions, mHealth tools should purposefully incorporate effective and developmentally appropriate BCTs. A cross-cutting approach to BCT selection could accelerate the development of much-needed mHealth interventions for target populations, although mHealth intervention developers should continue to consider the unique needs of the target population when designing these tools.